Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Renal Impairment”

258 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 258 results

Early research (Phase 1)Ended earlyNCT01359579
What this trial is testing

The Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function

Who this might be right for
Renal Impairment
Anthera Pharmaceuticals 28
Testing effectiveness (Phase 2)Study completedNCT03617536
What this trial is testing

Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Who this might be right for
Chronic Kidney DiseasesPruritus
Cara Therapeutics, Inc. 269
Large-scale testing (Phase 3)Study completedNCT00151827
What this trial is testing

Olmesartan Medoxomil in Hypertension and Renal Impairment

Who this might be right for
Essential HypertensionRenal Impairment
Sankyo Pharma Gmbh 393
Post-approval studies (Phase 4)Study completedNCT03778567
What this trial is testing

Renoprotective Effects of Telbivudine in Chronic Hepatitis B

Who this might be right for
Hepatitis B, ChronicChronic Kidney Diseases
The University of Hong Kong 31
Testing effectiveness (Phase 2)Study completedNCT01136564
What this trial is testing

Reno- and Vascular Protective Effect of a Vitamin-D-analogue in Moderate to Severe Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Erling Bjerregaard Pedersen 30
Not applicableNot Yet RecruitingNCT07751913
What this trial is testing

ProNephro NGAL Test for Early Detection of Acute Kidney Injury in Adult ICU Patients (ALPACA)

Who this might be right for
Acute Kidney Injury
BioPorto Diagnostics 800
Early research (Phase 1)Study completedNCT01374113
What this trial is testing

Safinamide Renal Impairment Trial

Who this might be right for
Renal Impairment
Newron Pharmaceuticals SPA 24
Early research (Phase 1)Study completedNCT00750620
What this trial is testing

A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Astellas Pharma Inc 33
Early research (Phase 1)Study completedNCT04142970
What this trial is testing

Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions

Who this might be right for
Chronic Renal Impairment
Sichuan Haisco Pharmaceutical Group Co., Ltd 24
Large-scale testing (Phase 3)Study completedNCT00646542
What this trial is testing

Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 525
Large-scale testing (Phase 3)Study completedNCT03242252
What this trial is testing

Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease Stage 3
Lexicon Pharmaceuticals 787
Early research (Phase 1)Study completedNCT05718843
What this trial is testing

Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems

Who this might be right for
Renal Insufficiency
Boehringer Ingelheim 36
Early research (Phase 1)Study completedNCT01555008
What this trial is testing

Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment

Who this might be right for
Type 2 Diabetes MellitusRenal Impairment
Lexicon Pharmaceuticals 31
Early research (Phase 1)Study completedNCT02096718
What this trial is testing

Afatinib in Subjects With Kidney Dysfunction

Who this might be right for
Renal Insufficiency
Boehringer Ingelheim 30
Testing effectiveness (Phase 2)WithdrawnNCT02848508
What this trial is testing

Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study

Who this might be right for
Renal Insufficiency, Chronic
Centre Hospitalier Universitaire, Amiens
Early research (Phase 1)Looking for participantsNCT07227922
What this trial is testing

Clofutriben Pharmacokinetics in Patients With Impaired Renal Function

Who this might be right for
Moderate Renal Impairment
Sparrow Pharmaceuticals 16
Large-scale testing (Phase 3)Study completedNCT03422653
What this trial is testing

Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)

Who this might be right for
Uremic Pruritus
Cara Therapeutics, Inc. 378
Early research (Phase 1)Study completedNCT05704556
What this trial is testing

Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Renal Impairment

Who this might be right for
Pain
Vertex Pharmaceuticals Incorporated 38
Early research (Phase 1)Ended earlyNCT02679131
What this trial is testing

To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.

Who this might be right for
Relapsed/Refractory Solid Tumors/Hematological Malignancies
Acrotech Biopharma Inc. 18
Testing effectiveness (Phase 2)Looking for participantsNCT06863194
What this trial is testing

Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial

Who this might be right for
Kidney Disease, ChronicRenal Insufficiency, ChronicGut Dysbiosis+1 more
Mansoura University 72
Next Page